DSCSA Pilot Used Blockchain To Trace Drug Through 'Last Mile' of Supply Chain
A blockchain application for mobile devices was successfully piloted to conduct real-time tracking of a high-cost drug through the “last mile” of the supply chain to the point of dispensing. Such a tool can be useful for manufacturers in tracing their products through the supply chain and complying with a forthcoming mandate of the US FDA Drug Supply Chain Security Act (DSCSA).
You may also be interested in...
Indegene’s chief technology officer, Tarun Mathur, talks to Scrip about blockchain’s potential in a number of areas across pharma’s operations including the clinical supply chain and trials as well as its role in enabling improved trust in the healthcare data ecosystem.
Agency recommends the GS1 standard that stakeholders have been focusing on for working together to remove counterfeits from the US pharmaceutical distribution chain; adds its latest thinking on roles of additional types of trading partners.
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.